Vaccine makers reduce research efforts and lay off employees
The changes come amid a broader trend in the pharmaceutical industry, where companies are reevaluating their investment in vaccine development. According to reports, Pfizer plans to reduce its workforce by up to 20% in certain divisions, while Moderna has already laid off approximately 100 employees as part of its restructuring efforts. These decisions reflect the … Read more